Co-development of a community pharmacy training regarding fentanyl and xylazine test strips

IF 1.8 Q3 PHARMACOLOGY & PHARMACY
Grace Marley , Cheryl Viracola , Ainsley Bryce , Anthony Hudson , Elizabeth Locklear , Bayla Ostrach , Delesha Carpenter
{"title":"Co-development of a community pharmacy training regarding fentanyl and xylazine test strips","authors":"Grace Marley ,&nbsp;Cheryl Viracola ,&nbsp;Ainsley Bryce ,&nbsp;Anthony Hudson ,&nbsp;Elizabeth Locklear ,&nbsp;Bayla Ostrach ,&nbsp;Delesha Carpenter","doi":"10.1016/j.rcsop.2024.100557","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Fentanyl and xylazine test strips (FTS, XTS) are simple point-of-care tests that determine the presence of fentanyl or xylazine in a substance before use. Access to FTS and XTS is limited. For pharmacists who are willing to sell an FTS, there is little guidance about how to implement FTS sales and counseling as no training for community pharmacists regarding FTS and XTS exists. This article describes how a FTS and XTS training for community pharmacists was co-designed.</div></div><div><h3>Methods</h3><div>A co-design strategy was utilized that involved an advisory panel of eight members: three practicing community pharmacists, two harm reduction experts, a website developer, the director of practice advancement for the state pharmacy association, and a patient-provider communication expert. A total of six meetings occurred to develop the training over seven months from July 2023 to February 2024. The advisory panel met once a month to discuss training goals, develop training information, and revise and structure the training to ensure the acceptability and appropriateness of the training for North Carolina community pharmacists.</div></div><div><h3>Results</h3><div>The co-design strategy led to the development of a 6-module 30-min training. Module topics included information that stakeholders felt was most important to include: (1): What and Why of Test Strips, (2) Why pharmacies? (3) How to use/ “Best practices of testing” (4) Logistics (5) FAQs and (6) Resources. Panelists determined an online self-paced webinar would be most useful for pharmacists to reference when needed.</div></div><div><h3>Conclusion</h3><div>The inclusion of stakeholders, including product end-users, leads to the creation of content that is salient and feasible for pharmacists to implement, which may increase their ability to integrate a new pharmacy service (FTS and XTS sales and counseling) into their pharmacy workflow.</div></div><div><h3>Patient or public contribution</h3><div>This training was developed through a co-design strategy for community pharmacists with community pharmacist input. This training also utilized feedback from harm reduction experts who have trained people who use drugs on the best practices of testing their substances with FTS and XTS. The incorporation of their feedback was integral to the development of this training and will ensure that the training is feasible for the pharmacist to integrate into their workflow.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"17 ","pages":"Article 100557"},"PeriodicalIF":1.8000,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11750552/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploratory research in clinical and social pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667276624001549","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Fentanyl and xylazine test strips (FTS, XTS) are simple point-of-care tests that determine the presence of fentanyl or xylazine in a substance before use. Access to FTS and XTS is limited. For pharmacists who are willing to sell an FTS, there is little guidance about how to implement FTS sales and counseling as no training for community pharmacists regarding FTS and XTS exists. This article describes how a FTS and XTS training for community pharmacists was co-designed.

Methods

A co-design strategy was utilized that involved an advisory panel of eight members: three practicing community pharmacists, two harm reduction experts, a website developer, the director of practice advancement for the state pharmacy association, and a patient-provider communication expert. A total of six meetings occurred to develop the training over seven months from July 2023 to February 2024. The advisory panel met once a month to discuss training goals, develop training information, and revise and structure the training to ensure the acceptability and appropriateness of the training for North Carolina community pharmacists.

Results

The co-design strategy led to the development of a 6-module 30-min training. Module topics included information that stakeholders felt was most important to include: (1): What and Why of Test Strips, (2) Why pharmacies? (3) How to use/ “Best practices of testing” (4) Logistics (5) FAQs and (6) Resources. Panelists determined an online self-paced webinar would be most useful for pharmacists to reference when needed.

Conclusion

The inclusion of stakeholders, including product end-users, leads to the creation of content that is salient and feasible for pharmacists to implement, which may increase their ability to integrate a new pharmacy service (FTS and XTS sales and counseling) into their pharmacy workflow.

Patient or public contribution

This training was developed through a co-design strategy for community pharmacists with community pharmacist input. This training also utilized feedback from harm reduction experts who have trained people who use drugs on the best practices of testing their substances with FTS and XTS. The incorporation of their feedback was integral to the development of this training and will ensure that the training is feasible for the pharmacist to integrate into their workflow.
共同开展芬太尼和噻嗪试纸条的社区药学培训。
芬太尼和噻嗪试纸条(FTS, XTS)是简单的即时检测,可在使用前确定物质中是否存在芬太尼或噻嗪。使用FTS和XTS是有限的。对于愿意销售FTS的药剂师,由于没有针对社区药剂师的FTS和XTS培训,因此很少有关于如何实施FTS销售和咨询的指导。本文描述了如何为社区药剂师共同设计FTS和XTS培训。方法:采用共同设计策略,其中包括一个由八名成员组成的咨询小组:三名执业社区药剂师,两名减少危害专家,一名网站开发人员,州药房协会实践进步主任和一名患者-提供者沟通专家。从2023年7月到2024年2月,共举行了6次会议来开发培训。咨询小组每月召开一次会议,讨论培训目标,开发培训信息,修改和组织培训,以确保北卡罗莱纳州社区药剂师培训的可接受性和适当性。结果:协同设计策略导致了6个模块30分钟培训的发展。模块主题包括利益相关者认为最重要的信息,包括:(1):试纸的内容和原因,(2)为什么是药店?(3)如何使用/“最佳测试实践”(4)物流(5)常见问题解答(6)资源。小组成员确定在线自定进度的网络研讨会将是药剂师在需要时参考的最有用的。结论:包括产品最终用户在内的利益相关者的参与,可以创造出对药剂师来说是显著和可行的内容,这可能会提高他们将新的药学服务(FTS和XTS销售和咨询)整合到他们的药学工作流程中的能力。患者或公众贡献:该培训是通过社区药剂师的共同设计策略与社区药剂师的投入来开发的。这次培训还利用了减少危害专家的反馈,这些专家对吸毒者进行了关于用FTS和XTS测试其物质的最佳做法的培训。将他们的反馈纳入培训的发展是不可或缺的,并将确保培训对药剂师来说是可行的,可以整合到他们的工作流程中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
0
审稿时长
103 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信